{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:31:17Z","timestamp":1776259877171,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":501,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2009\/51897-5"],"award-info":[{"award-number":["2009\/51897-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2010\/10749-0"],"award-info":[{"award-number":["2010\/10749-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["302724\/2011-7"],"award-info":[{"award-number":["302724\/2011-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["301411\/2009-3"],"award-info":[{"award-number":["301411\/2009-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Federico Foundation"},{"DOI":"10.13039\/501100005942","name":"Butantan Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.10.063","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T20:16:09Z","timestamp":1351628169000},"page":"202-206","source":"Crossref","is-referenced-by-count":20,"title":["Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Samuel Katsuyuki","family":"Shinjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falio C\u00e9sar Bertacini","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maur\u00edcio","family":"Levy-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e1dia Emi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"de Medeiros Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Gon\u00e7alves","family":"Schahin Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Precioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clovis Artur","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.10.063_bib0005","first-page":"453","article-title":"Update: novel influenza A (H1N1) virus infections-worldwide, May 6, 2009","volume":"58","author":"Centers for Disease Control Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PEC.0b013e3181c3c8f8","article-title":"Novel influenza A (H1N1): clinical presentation, diagnosis, and management","volume":"25","author":"Jain","year":"2009","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0015","first-page":"682","article-title":"Deaths and hospitalizations related to 2009 pandemic influenza A (H1N1): Greece, May 2009\u2013February 2010","volume":"59","author":"Centers for Disease Control Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0020","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0030","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","article-title":"The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Elkayam","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0040","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/art.30325","article-title":"Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study","volume":"63","author":"Gabay","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/INF.0b013e3181f7ce44","article-title":"Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents","volume":"30","author":"Ogimi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1177\/0961203309345734","article-title":"Vaccines as a trigger for myopathies","volume":"18","author":"Orbach","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0055","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/0264-410X(94)90166-X","article-title":"Influenza vaccine and dermatomyositis","volume":"12","author":"Jani","year":"1994","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.063_bib0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(82)90520-7","article-title":"Influenza vaccine and dermatomyositis","volume":"28","author":"Winkelmann","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00296-007-0485-4","article-title":"HBV vaccine and dermatomyositis: is there an association","volume":"28","author":"Altman","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0070","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/ard.2011.150250","article-title":"Immunogenicity and safety of the 2009 non-adjuvanted influenza A\/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases","volume":"70","author":"Saad","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"13","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0080","first-page":"705","article-title":"Update: influenza activity \u2013 United States, 2010\u201311 season, and composition of the 2011\u201312 influenza vaccine","volume":"60","author":"Centers for Disease Control Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0085","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0090","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/art.1780401109","article-title":"Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments","volume":"40","author":"Rider","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0095","first-page":"603","article-title":"Defining clinical improvement in adult and juvenile myositis","volume":"30","author":"Rider","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0100","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203309345724","article-title":"Adjuvants and autoimmunity","volume":"18","author":"Israeli","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 \u2013 autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203311429550","article-title":"Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome","volume":"21","author":"Katzav","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.110721","article-title":"Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease","volume":"39","author":"Aikawa","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/rheumatology\/ker427","article-title":"Influenza A\/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?","volume":"51","author":"Borba","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2012.10.063_bib0130","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1136\/ard.2011.152983","article-title":"Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice","volume":"70","author":"Ribeiro","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201523X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201523X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T18:55:49Z","timestamp":1542653749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201523X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X1201523X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}